Immune thrombocytopenia, known as primary immune thrombocytopenia, is an autoimmune disease that usually does not turn into reoccurrence and is mostly treated with medication. Primary immune thrombocytopenia mainly refers to the disorder of hematopoietic system caused by immune dysfunction, which leads to clinical symptoms of thrombocytopenia. Primary immune thrombocytopenia is preferred to glucocorticoid therapy, such as prednisone, which can further restore the platelet count by inhibiting the body from producing anti-platelet antibodies. After the platelets are restored to normal, the dosage can be gradually reduced. If bleeding is severe, treatment with gammaglobulin infusion or intravenous platelet transfusion can be performed. If severe bleeding symptoms occur in thrombocytopenia, it is necessary to consult a doctor in time and receive standardized treatment under the guidance of a physician to avoid delaying the condition.